Biotech · Private company
GenSight Biologics
Track this companyFree. Adds GenSight Biologics to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- GS010Phase 3 · Leber Hereditary Optic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- GS010Phase 3 · Optic, Atrophy, Hereditary, LeberClinicalTrials.gov · fetched Nov 12, 2026
- Sham Intravitreal InjectionPhase 3 · Leber Hereditary Optic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Sham Intravitreal InjectionPhase 3 · Optic, Atrophy, Hereditary, LeberClinicalTrials.gov · fetched Nov 12, 2026
- Gene therapy: GS030-DP AND Medical device: GS030-MDPhase 2 · Non-syndromic Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Patient-reported outcomes (PROs)Leber Hereditary Optic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis PigmentosaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 26, 2018ClinicalTrials.gov NCT03326336 · fetched Nov 12, 2026
- Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 YearPHASE3 · COMPLETED · started Mar 12, 2018ClinicalTrials.gov NCT03293524 · fetched Nov 12, 2026
- RESCUE and REVERSE Long-term Follow-upPHASE3 · COMPLETED · started Jan 9, 2018ClinicalTrials.gov NCT03406104 · fetched Nov 12, 2026
- REALITY LHON RegistryCOMPLETED · started Jan 3, 2018ClinicalTrials.gov NCT03295071 · fetched Nov 12, 2026
- Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 MutationPHASE3 · COMPLETED · started Feb 23, 2016ClinicalTrials.gov NCT02652767 · fetched Nov 12, 2026
- Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)PHASE3 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02652780 · fetched Nov 12, 2026